Steven Michael Lutz

All filings by Steven Michael Lutz on record concern Critical Therapeutics Inc. In total, 3 filings cover trades dated from 31 October 2008 to 16 December 2010.

No open-market purchase appears, only 2 sales worth €1.7M. Besides market trades, the filings include 1 share grant. So far in 2010, the count stands at no purchases and 1 sale.

The latest filing, published on 20 December 2010, reports an open-market sale of €296k in Critical Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.